Advertisement

Agents and Actions

, Volume 20, Issue 1–2, pp 93–97 | Cite as

The inhibition by morphine andd-aspartic acid of antibody production against Salmonella typhimurium antigen in rats: its antagonism byl-aspartic acid

  • H. Koyuncouĝlu
  • Ö Anĝ
  • D. Inanç
  • H. Saĝduyu
  • M. Güngör
Immunosuppression and Inflammation

Abstract

The changes in the production of antibody against Salmonella typhimurium antigen were investigated in rats by means of the agglutination test after chronic oral administration of the,l-asparaginase inhibitors morphine (M) ord-aspartic acid (d-Asp) alone or together withl-aspartic acid (l-Asp) and food restriction, all of which had been started five days before the injections of antigen. The statistical evaluation, carried out after the titers had been defined as-log2 of the highest dilution giving a positive agglutination reaction, showed that M ord-Asp significantly decreased antibody production in comparison with the immunized control or food restricted group. The concomitant administration ofl-Asp appeared to significantly antagonize the inhibitory effect of both M andd-Asp. Therefore, the results were considered as further supporting evidence for the fact that the deleterious effect of M on the immune system and its functions might be related to the inhibitory effect of M onl-asparaginase activity.

Keywords

Immune System Morphine Oral Administration Deleterious Effect Statistical Evaluation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. [1]
    C. E. Cherubin,The medical sequelae of narcotic addiction. Ann. Int. Med.67, 23–33 (1967).PubMedGoogle Scholar
  2. [2]
    D. B. Louria, T. Hensle and J. Rose,The major medical complications of heroin addition. Ann. Int. Med.67, 1–22 (1967).PubMedGoogle Scholar
  3. [3]
    M. Güngör, E. Genç, H. Saĝduyu, L. Eroĝlu and H. Koyuncuoĝlu,Effect of chronic administration of morphine on primary immune response in mice. Experentia36, 1309–1310 (1980).Google Scholar
  4. [4]
    S. S. Lefkowitz and C. Y. Chiang,Effects of certain abused drugs in hemolysin forming cells. Life Sci.17, 1763–1768 (1975).PubMedGoogle Scholar
  5. [5]
    H. Koyuncuoĝlu, M. Güngör, H. Koĝduyu and L. Eroĝlu,The antagonistic effects of aspartic acid on some effects of morphine on rats. Eur. J. Pharmacol.27, 148–150 (1974).PubMedGoogle Scholar
  6. [6]
    H. Koyuncuoĝlu, H. Saĝduyu, M. Güngör, L. Eroĝlu and E. Genç,Antagonizing effect of aspartic acid on the development of physical dependence on and tolerance to morphine in the rat. Drug. Res.27, 1676–1679 (1977).Google Scholar
  7. [7]
    H. Koyuncuoĝlu, E. Genç, M. Güngör, L. Eroĝlu and H. Saĝduyu,The antagonizing effect of aspartic acid on the brain levels of monoamines and free amino acids during the development of tolerance to and physical dependence on morphine. Psychopharmacology54, 187–191 (1977).PubMedGoogle Scholar
  8. [8]
    L. Eroĝlu and H. Koyuncuoĝlu,The effect of aspartic acid on the intensity of physical dependence in morphine dependent mice. Pol. J. Pharmacol. Pharm.31, 83–88 (1979).PubMedGoogle Scholar
  9. [9]
    H. Koyuncuoĝlu, M. Güngör, L. Eroĝlu and H. Saĝduyu,The antagonizing effect of aspartic acid on morphine withdrawal and levallorphan-precipitated abstinence syndrome signs and on associated changes in brain levels of free amino acids in the rat. Psychopharmacology62, 89–95 (1979).PubMedGoogle Scholar
  10. [10]
    H. Koyuncuoĝlu, K. Meyer-Uysal, K. Berkman, M. Güngör and E. Genç,The relationship between morphine, aspartic acid and l-asparaginase in rats. Eur. J. Pharmacol60, 369–372 (1979).PubMedGoogle Scholar
  11. [11]
    H. Koyuncuoĝlu,The treatment with l-aspartic acid of persons addicted to opiates. Bull. Narcotics35, 11–15 (1983).Google Scholar
  12. [12]
    H. Koyuncuoĝlu, K. Berkman, I. Hatipoĝlu and H. Sabuncu,Vasopressin release by d-aspartic acid, morphine and prolyl-leucyl-glycinamide (PLG) in DI Brattleboro rats. Pharmacol. Biochem. Behav.20, 519–526 (1984).PubMedGoogle Scholar
  13. [13]
    A. I. Şener, M. E. Ceylan and H. Koyuncuoĝlu,The comparison of the suppressive effects of l-aspartic acid and chlorpromazine+diazepam treatments on opiate abstinence syndrome signs in men. Drug Res. (in press).Google Scholar
  14. [14]
    M. I. Lerman and I. V. Verevkina,The inhibition of asparaginase from the blood serum of guinea pigs. Biokhimiya27, 526–531 (1962).Google Scholar
  15. [15]
    H. Koyuncuoĝlu, J. Wildmann, K. Berkman and H. Matthaei,The effects of d- and/orl-aspartic acid on the total weight of body and the weights of certain organs and their protein, triglyceride and glycogen contents. Drug Res.32, 738–741 (1982).Google Scholar
  16. [16]
    H. Koyuncuoĝlu, K. Berkman, J. Wildmann and H. Matthaei,Antagonistic effect of l-aspartic acid on decrease in body weight, food and fluid intake, and naloxone reversible rectal temperature caused by d-aspartic acid. Pol. J. Pharmacol. Pharm.34, 333–337 (1982).PubMedGoogle Scholar
  17. [17]
    H. Koyuncuoĝlu and K. Berkman,Effect of d-and/orl-aspartic acids on feeding, drinking, urine outflow and core temperature. Pharmacol. Biochem. Behav.17, 1265–1269 (1982).PubMedGoogle Scholar
  18. [18]
    H. Koyuncuoĝlu, I. Hatipoĝlu and N. Enginar,The effect of morphine, naloxone,d-andl-aspartic acid on the brain and lung ACE in mice. Pharmacol. Res. Comm.15, 969–978 (1983).Google Scholar
  19. [19]
    H. Koyuncuoĝlu, K. Berkman and H. Sabuncu,Feeding, drinking, urine osmolality in Brattleboro rats: Changes by morphine, naloxone,d-amino acids, PLG. Pharmacol. Biochem. Behav.20, 29–34 (1984).PubMedGoogle Scholar
  20. [20]
    H. Koyuncuoĝlu, K. Berkman and H. Matthaei,Effects of morphine,d-aspartic acid,d-phenylalanine,d-leucine and PLG onl-asparaginase activity in rats. Med. Bull. Istanbul17, 1–6 (1984).Google Scholar
  21. [21]
    M. Güngör, Ö. Anĝ, V. Uysal, H. Saĝduyu, D. Inanç, M. Anĝ and H. Koyuncuoĝlu,Comparison of the development of experimental pyelonephritis in homozygous Brattleboro diabetes insipidus rats, heterozygous control rats and normal Wistar rats. Infection13, 82–84 (1985).PubMedGoogle Scholar
  22. [22]
    D. deWied and W. H. Gispen,Impaired development of tolerance to morphine analgesia in rats with hereditary diabetes insipidus. Psychopharmacologia46, 27–29 (1976).PubMedGoogle Scholar
  23. [23]
    H. Koyuncuoĝlu and M. Güngör, “Effects of Morphine Opiates on Immune Function” InEnkephalins and Endorphins: Stress and the Immune System”, (Eds. N. P. Plotnikoff, R. E. Faith, A. J. Murgo and R. A. Good) Plenum Pub. Cor. New York, pp. 347–365.Google Scholar
  24. [24]
    E. S. Tecoma and L. Y. Huey,Psychic distress and the immune response. Life. Sci.36, 1799–1812 (1985).PubMedGoogle Scholar
  25. [25]
    J. Wybran, T. Appelboom, J.-P. Famaey and A. Govaerts,Suggestive evidence for receptors for morphine and methionine-enkephalin on normal human blood T lymphocytes. J. Immunol.123, 1068–1070 (1979).PubMedGoogle Scholar
  26. [26]
    E. Hazum, K.-J. Chang and P. Cuatrecasas,Specific nonopiate receptors for β-endorphins. Science205, 1033–1035 (1979).PubMedGoogle Scholar
  27. [27]
    L. Schweigerer, S. Bhakdi and H. Teschemacher,Specific non-opiate binding sites for human β-endorphin on the terminal complex of human complement. Nature (Lond.)296, 572–574 (1982).Google Scholar
  28. [28]
    H. M. Johnson, E. M. Smith and B. A. Torres and J. E. Blalock,Regulation of the in vitro antibody response by neuroendocrine hormones. Proc. Natl. Acad. Sci.79, 4171–4174 (1982).PubMedGoogle Scholar
  29. [29]
    C. Y. Hung, S. S. Lefkowitz and W. F. Geber,Interferon inhibition by narcotic analgesics. Proc. Soc. exp. Biol. Med.142, 106–111 (1973).PubMedGoogle Scholar
  30. [30]
    H. W. McCain, I. B. Lamster, J. M. Bozzone and J. T. Gabic,β-endorphin modulates human immune activity via non-opiate receptor mechanisms. Life Sci.31, 1619–1624 (1982).PubMedGoogle Scholar
  31. [31]
    P. M. Mathews, W. L. Sibbitt and A. D. Bankhurst,The modulation of human natural killer cells by endorphins. Clin. Res.30, 54A (1982).Google Scholar
  32. [32]
    P. M. Mathews, C. J. Froelich, W. L. Sibbitt and A. D. Bankhurst,Enhancement of natural cytotoxicity by β-endorphin. J. Immunology130, 1658–1662 (1983).Google Scholar
  33. [33]
    N. E. Kay and J. E. Morley,β-endorphin enhances human natural killer (NK) cell activity. Clin. Res.31, 346A (1983).Google Scholar
  34. [34]
    E. G. Fischer and N. E. Falke,β-Endorphin Modulates Immune Functions, In: “Psychotherapy and Psychosomatic”. Proceedings of the VIIth. World Congress of the International College of Psychosomatic Medicine, 17–22 July 1983, Hamburg, W.-Germany, Karger, Basel (1984).Google Scholar
  35. [35]
    J. Wybran, Enkephalins,Endorphins, Substance P, and the Immune System, In “Neural Modulation of Immunity” edited by R. Guillemin, M. Cohn and T. Melnechuk. Raven Press, New York, pp. 157–161 (1984).Google Scholar
  36. [36]
    W. F. Geber, S. S. Lefkowitz and C. Y. Hung,Action of naloxone on the interferon-lowering activity of morphine in the mouse. Pharmacology14, 322–329 (1976).PubMedGoogle Scholar
  37. [37]
    W. F. Geber, S. S. Lefkowitz and C. Y. Hung,Effect of morphine, hydromorphone, methadone, mescaline, trypan blue, vitamin A, sodium salicylate, and caffeine on the serum interferon level in response to viral infection. Arch. Int. Pharmacodyn.214, 322–327 (1975).PubMedGoogle Scholar
  38. [38]
    W. F. Geber, S. S. Lefkowitz and C. Y. Hung,Role of spleen in the interferon-lowering action of morphine. Gen. Pharmacol.7, 255–258 (1976).PubMedGoogle Scholar
  39. [39]
    W. F. Geber, S. S. Lefkowitz and C. Y. Hung,Duration of interferon inhibition following single and multiple injections of morphine. J. Toxicol. Environ. Health2, 577–582 (1977).PubMedGoogle Scholar

Copyright information

© Birkhäuser Verlag 1987

Authors and Affiliations

  • H. Koyuncouĝlu
    • 1
  • Ö Anĝ
    • 2
  • D. Inanç
    • 3
  • H. Saĝduyu
    • 1
  • M. Güngör
    • 1
  1. 1.Dept. of Pharmacology/Istanbul Medical FacultyCapa/IstanbulTurkey
  2. 2.Dept. of Microbiology/Istanbul Medical FacultyCapa/IstanbulTurkey
  3. 3.Dept. of Microbiology/Faculty of DentistryCapa/IstanbulTurkey

Personalised recommendations